Lee, T.-I.; Chen, Y.-C.; Lin, Y.-K.; Chung, C.-C.; Lu, Y.-Y.; Kao, Y.-H.; Chen, Y.-J.
Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats. Int. J. Mol. Sci. 2019, 20, 1680.
https://doi.org/10.3390/ijms20071680
AMA Style
Lee T-I, Chen Y-C, Lin Y-K, Chung C-C, Lu Y-Y, Kao Y-H, Chen Y-J.
Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats. International Journal of Molecular Sciences. 2019; 20(7):1680.
https://doi.org/10.3390/ijms20071680
Chicago/Turabian Style
Lee, Ting-I, Yao-Chang Chen, Yung-Kuo Lin, Cheng-Chih Chung, Yen-Yu Lu, Yu-Hsun Kao, and Yi-Jen Chen.
2019. "Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats" International Journal of Molecular Sciences 20, no. 7: 1680.
https://doi.org/10.3390/ijms20071680
APA Style
Lee, T. -I., Chen, Y. -C., Lin, Y. -K., Chung, C. -C., Lu, Y. -Y., Kao, Y. -H., & Chen, Y. -J.
(2019). Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats. International Journal of Molecular Sciences, 20(7), 1680.
https://doi.org/10.3390/ijms20071680